iSOFT Wins new e-Prescribing Deal at Harrogate NHS Trust

iSOFTHarrogate and District NHS Foundation Trust is the latest NHS trust to place an order with iSOFT, a CSC company, for its e-prescribing and medicines administration (ePMA) solution to improve medicines management and reduce the risk of drug-related mistakes.

The move is part of the trust's commitment to ensuring safe and effective care at the 367-bed Harrogate District Hospital. The ePMA solution will integrate with the trust's existing IT infrastructure including PAS, laboratory and eDischarge systems to further promote the timely and accurate sharing of medicines related information within the trust and with GPs.

"We are dedicated to making the safety of our patients and the quality of care our highest priority," said Andrew Alldred, Harrogate's director of pharmacy. "With the proliferation of new drugs, many with similar sounding names, prescribing has become a hugely complex task that is fraught with risk. Paper-based medicines systems can no longer be relied on to meet the demanding needs of a modern and clinically complex hospital environment."

"With research suggesting that at least ten percent of medication orders contain errors, costing the NHS in excess of £500 million a year, there has never been a greater need for ePMA solutions to help improve the timeliness, appropriateness and accuracy of the prescribing and administration of medicines," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "Our solution has been shown to greatly reduce adverse medication errors and improve the efficiency of healthcare services."

Harrogate is the fourth NHS trust to become an early adopter of iSOFT's ePMA solution after Pennine Acute, Stockport and Leicester. "Harrogate is a welcome addition to the early adopter programme," Stevens said. "The trust has already achieved an impressive range of meaningful clinical engagement and we are looking forward to continuing our strategic relationship to deliver real benefits for the trust’s staff and its patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management underpinned by clinical and workflow based decision support provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

iSOFT ePMA is shown to halve adverse medication errors at hospitals in Australia and New Zealand. These errors can prolong a patient's stay, which in turn blocks hospital beds and increases costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...